Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

Muscle Nerve. 2016 Feb;53(2):165-8. doi: 10.1002/mus.25009. Epub 2015 Dec 21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • 4-Aminopyridine / analogs & derivatives*
  • 4-Aminopyridine / therapeutic use
  • Amifampridine
  • Humans
  • Neuromuscular Junction Diseases / drug therapy*
  • Neuromuscular Junction Diseases / economics
  • Orphan Drug Production* / economics
  • Orphan Drug Production* / methods
  • Physicians / psychology*
  • Potassium Channel Blockers / therapeutic use*

Substances

  • Potassium Channel Blockers
  • 4-Aminopyridine
  • Amifampridine